FTH1P7: A Potential Drug Target and Biomarker (G2500)
FTH1P7: A Potential Drug Target and Biomarker
FTH1P7, also known as FTHL7, is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the Fth1 family of proteins, which are known for their role in cell signaling and inflammation. The FTH1P7 gene has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The FTH1P7 protein is involved in a variety of cellular processes that are important for normal tissue growth and development. It is a key regulator of cell adhesion and has been shown to play a role in the development and progression of various diseases. For example, studies have shown that FTH1P7 is involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, FTH1P7 has been shown to be involved in the development of cancer, with several studies suggesting that it may be a potential cancer biomarker.
FTH1P7 has also been shown to be involved in inflammation, which is a critical aspect of many diseases, including cancer. Studies have shown that FTH1P7 is involved in the regulation of immune responses and that it plays a role in the development of autoimmune disorders. This suggests that FTH1P7 may be a potential biomarker for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.
In addition to its potential role as a drug target and biomarker, FTH1P7 is also of interest to researchers because of its unique structure and biology. Studies have shown that FTH1P7 is a glycoprotein, which means that it is composed of both protein and carbohydrate components. This is unique because most proteins are composed only of protein components. The combination of protein and carbohydrate components in FTH1P7 makes it a complex and interesting molecule that is worth further research.
FTH1P7 has also been shown to play a role in the regulation of cellular processes that are important for normal development and growth. Studies have shown that FTH1P7 is involved in the development and maintenance of neuronal stem cells, which are important for the development and function of the brain. Additionally, FTH1P7 is involved in the regulation of cellular processes that are important for the development and growth of tissues, such as muscle and bones.
In conclusion, FTH1P7 is a protein that is expressed in various tissues throughout the body and is involved in a variety of cellular processes that are important for normal tissue growth and development. Its unique structure and biology make it a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of FTH1P7 in disease development and to develop effective treatments.
Protein Name: Ferritin Heavy Chain 1 Pseudogene 7
The "FTH1P7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FTH1P7 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2 | GABARAPL3 | GABBR1 | GABBR2 | GABPA | GABPAP | GABPB1 | GABPB1-AS1 | GABPB1-IT1 | GABPB2 | GABRA1
